Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'Amgen'  -  Page 30
Latest

Annual report shows tax reform hit Amgen hard

By   /  Thursday, February 1st, 2018  /  Latest news  /  Comments Off on Annual report shows tax reform hit Amgen hard

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen gets FDA approval to change Kyprolis label

By   /  Thursday, January 18th, 2018  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Amgen gets FDA approval to change Kyprolis label

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen seeking European approval of osteoporosis drug Evinity

By   /  Monday, January 8th, 2018  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen seeking European approval of osteoporosis drug Evinity

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Dubroff: Gazing into my crystal ball to predict 2018 developments

By   /  Friday, January 5th, 2018  /  Columns, Latest news  /  Comments Off on Dubroff: Gazing into my crystal ball to predict 2018 developments

Henry Dubroff

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen planning to bring back stranded overseas cash

By   /  Friday, January 5th, 2018  /  Central Coast Health Watch, East Ventura County, left, Technology, Tri-County Public Companies  /  Comments Off on Amgen planning to bring back stranded overseas cash

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen wins new FDA approval for cancer drug Xgeva

By   /  Friday, January 5th, 2018  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen wins new FDA approval for cancer drug Xgeva

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen says repatriating earnings held overseas to cost it $6B in taxes

By   /  Tuesday, December 26th, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen says repatriating earnings held overseas to cost it $6B in taxes

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →